Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PARP1 | P09874 | 3/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.54 |
| ▸ | MAOA | P21397 | 5/20 | 0.54 |
| ▸ | MAOB | P27338 | 5/20 | 0.54 |
| ▸ | ACHE | P22303 | 2/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.54 |
| ▸ | HPGD | P15428 | 2/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.54 |
| ▸ | GABRP | O00591 | 1/20 | 0.54 |
| ▸ | GABRD | O14764 | 1/20 | 0.54 |
| ▸ | IKBKB | O14920 | 1/20 | 0.54 |
| ▸ | AURKA | O14965 | 1/20 | 0.54 |
| ▸ | CHUK | O15111 | 1/20 | 0.54 |
| ▸ | PIM1 | P11309 | 1/20 | 0.54 |
| ▸ | TOP1 | P11387 | 1/20 | 0.54 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.54 |
| ▸ | IDO1 | P14902 | 1/20 | 0.54 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.54 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.54 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17298998 | 1.00 | PARP1 (0.55) | PARP1KDM4EMAOAMAOBACHE | |
| SCHEMBL15374721 | 1.00 | PARP1 (0.55) | PARP1KDM4EMAOAMAOBACHE | |
| SCHEMBL15374747 | 1.00 | PARP1 (0.55) | PARP1KDM4EMAOAMAOBACHE | |
| SCHEMBL21297781 | 0.90 | KDM4E (0.54) | PARP1KDM4EMAOAMAOBACHE | |
| SCHEMBL22048844 | 0.89 | PARP1 (0.52) | PARP1KDM4EMAOAMAOBACHE | |
| SCHEMBL16231036 | 0.86 | PARP1 (0.46) | PARP1KDM4EMAOAMAOBACHE | |
| SCHEMBL16230973 | 0.86 | PARP1 (0.46) | PARP1KDM4EMAOAMAOBACHE | |
| SCHEMBL16231012 | 0.86 | PARP1 (0.46) | PARP1KDM4EMAOAMAOBACHE | |
| SCHEMBL21297780 | 0.85 | KDM4E (0.59) | PARP1KDM4EMAOAMAOBACHE | |
| SCHEMBL20698679 | 0.84 | NPC1 (0.48) | PARP1KDM4EMAOAMAOBACHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 132 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3356369-B1 | BENZIMIDAZOLO[1,2-A]BENZIMIDAZOLE CARRYING TRIAZINE GROUPS FOR ORGANIC LIGHT EMITTING DIODES | IDEMITSU KOSAN CO (JP) | 2022-05-04 | — | — | EP | claimed |
| US-20180269407-A1 | BENZIMIDAZOLO[1,2-A]BENZIMIDAZOLE CARRYING TRIAZINE GROUPS FOR ORGANIC LIGHT EMITTING DIODES | IDEMITSU KOSAN CO., LTD. (JP) | 2018-09-20 | — | — | US | claimed |
| EP-3356369-A1 | BENZIMIDAZOLO[1,2-A]BENZIMIDAZOLE CARRYING TRIAZINE GROUPS FOR ORGANIC LIGHT EMITTING DIODES | Idemitsu Kosan Co., Ltd (JP) | 2018-08-08 | — | — | EP | claimed |
| WO-2007103884-A2 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF MULTIPLE SCLEROSIS | AMPLIMED CORPORATION (US) | 2007-09-13 | — | — | WO | claimed |
| US-20070213354-A1 | Compositions and Methods for the Treatment of Multiple Sclerosis | AMPLIMED CORPORATION (US) | 2007-09-13 | — | — | US | claimed |
| EP-1787985-A1 | Azonafide derivatives, methods for their production and pharmaceutical compositions therefrom | Unibioscreen S.A. (BE) | 2007-05-23 | — | — | EP | claimed |
| US-7101530-B2 | catalytically saturating polycyclic aromatic hydrocarbons for storage, then dehydrogenation with catalyst to release hydrogen; supplying hydrogen to fuel cells | AIR PRODUCTS AND CHEMICALS, INC. (US) | 2006-09-05 | — | — | US | claimed |
| EP-3715352-B1 | ORGANOMETALLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND ELECTRONIC APPARATUS INCLUDING THE ORGANIC LIGHT-EMITTING DEVICE | SAMSUNG ELECTRONICS CO LTD (KR) | 2025-07-30 | — | — | EP | disclosed |
| US-20240341169-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2024-10-10 | — | — | US | disclosed |
| US-12022727-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2024-06-25 | — | — | US | disclosed |
| US-20230365857-A1 | ORGANIC MIXTURES AND APPLICATIONS THEREOF IN ORGANIC ELECTRONIC DEVICES | Zhejiang Brilliant Optoelectronic Technology Co.,Ltd. (CN) | 2023-11-16 | — | — | US | disclosed |
| US-20230365857-A1 | ORGANIC MIXTURES AND APPLICATIONS THEREOF IN ORGANIC ELECTRONIC DEVICES | Zhejiang Brilliant Optoelectronic Technology Co.,Ltd. (CN) | 2023-11-16 | — | — | US | disclosed |
| US-20230131934-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2023-04-27 | — | — | US | disclosed |
| WO-1994006771-A9 | 1,2 DIHYDRO-3-H-DIBENZ(de,h) ISOQUINOLINE 1,3 DIONE AND THEIR USE AS ANTICANCER AGENTS | — | 1994-06-09 | — | — | WO | disclosed |
| WO-1994006771-A1 | 1,2 DIHYDRO-3-H-DIBENZ(de,h) ISOQUINOLINE 1,3 DIONE AND THEIR USE AS ANTICANCER AGENTS | RESEARCH CORPORATION TECHNOLOGIES, INC. (US) | 1994-03-31 | — | — | WO | disclosed |
| EP-0536208-A4 | 1,2-DIHYDRO-3H-DIBENZISOQUINOLINE-1,3-DIONE ANTICANCER AGENTS | — | 1993-05-05 | — | — | EP | disclosed |
| EP-0536208-A1 | 1,2-DIHYDRO-3H-DIBENZISOQUINOLINE-1,3-DIONE ANTICANCER AGENTS | RESEARCH CORPORATION TECHNOLOGIES, INC. (US) | 1993-04-14 | — | — | EP | disclosed |
| WO-1992000281-A1 | 1,2-DIHYDRO-3H-DIBENZISOQUINOLINE-1,3-DIONE ANTICANCER AGENTS | RESEARCH CORPORATION TECHNOLOGIES, INC. (US) | 1992-01-09 | — | — | WO | disclosed |
| EP-0288399-A3 | POLYESTERS HAVING IMPROVED WHITENESS | EASTMAN KODAK COMPANY (a New Jersey corporation) (US) | 1990-03-07 | — | — | EP | disclosed |
| EP-0288399-A2 | Polyesters having improved whiteness | EASTMAN KODAK COMPANY (a New Jersey corporation) (US) | 1988-10-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230365857-A1 | ORGANIC MIXTURES AND APPLICATIONS THEREOF IN ORGANIC ELECTRONIC DEVICES | H1-0, OR10J3, H1-2 | PARP1 3776/4885KDM4E 3438/4885MAOA 79/4885 |
| US-20240341169-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OCIAD1, OSBP, OCIAD2 | PARP1 1555/4885KDM4E 4507/4885MAOA 607/4885 |
| US-20180269407-A1 | BENZIMIDAZOLO[1,2-A]BENZIMIDAZOLE CARRYING TRIAZINE GROUPS FOR ORGANIC LIGHT EMITTING DIODES | ALDH1A2, TRPA1, CDK2 | PARP1 3151/4885KDM4E 977/4885MAOA 845/4885 |
| US-12022727-B2 | Organic electroluminescent materials and devices | OCIAD1, OSBP, OCIAD2 | PARP1 1555/4885KDM4E 4507/4885MAOA 607/4885 |
| US-20070213354-A1 | Compositions and Methods for the Treatment of Multiple Sclerosis | C9, CBR3, CHRM2 | PARP1 3510/4885KDM4E 2622/4885MAOA 1995/4885 |
| US-20230131934-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OCIAD1, OCIAD2, OSBP | PARP1 1094/4885KDM4E 4278/4885MAOA 1466/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.